Docetaxel-loaded thermosensitive and bioadhesive nanomicelles as a rectal drug delivery system for enhanced chemotherapeutic effect

Pharmaceutical Research

Volumn 30, Issue 7, 2013, Pages 1860-1870

  Seo, Youn Gee ^a   Kim, Dong Wuk ^b   Yeo, Woo Hyun ^a   Ramasamy, Thiruganesh ^a   Oh, Yu Kyoung ^c   Park, Young Joon ^d   Kim, Jung Ae ^a   Oh, Dong Hoon ^a   Ku, Sae Kwang ^e   Kim, Jin Ki ^b   Yong, Chul Soon ^a   Kim, Jong Oh ^a   Choi, Han Gon ^a,b  

^a Yeungnam University   (South Korea)

^b Hanyang University   (South Korea)

^c Seoul National University   (South Korea)

^d Samil Pharmaceutical Co Ltd   (South Korea)

^e Daegu Haany University   (South Korea)

Author keywords

anti cancer effect; docetaxel; liquid suppository; rectal delivery; thermosensitive and bioadhesive nanomicelles

Indexed keywords

DOCETAXEL; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; EMULSION; FEMALE; FIRST PASS EFFECT; HEAT SENSITIVITY; HISTOPATHOLOGY; HYDRODYNAMICS; IN VIVO STUDY; LIGHT SCATTERING; MALE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; RECTAL DRUG DELIVERY SYSTEM; RECTUM MUCOSA; TRANSMISSION ELECTRON MICROSCOPY; VISCOELASTICITY;

ADMINISTRATION, RECTAL; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; FEMALE; MALE; MICE, NUDE; MICELLES; NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RECTUM; TAXOIDS;

EID: 84878843283     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1029-0     Document Type: Article

References (38)

1. Kintzel PE, Michaud LB, Lange MK. Docetaxel-associated epiphora. Pharmacotherapy. 2006;26:853-67. (Pubitemid 43807636)
2. Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Lee JH, et al. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic for tumor-targeted delivery of docetaxel. Biomaterials. 2011;32:7181-90.
3. Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, André S. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol. 1995;22:3-16.
4. Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: a review. Anticancer Drugs. 2007;18:95-103. (Pubitemid 44967420)
5. Gelderblom H, Loos WJ, Verweij J, van der Burg ME, de Jonge MJ, Brouwer E, et al. Modulation of cisplatin pharmacodynamics by Cremophor EL: experimental and clinical studies. Eur J Cancer. 2002;38:205-13. (Pubitemid 34031837)
6. Yan YD, Kim DH, Sung JH, Yong CS, Choi HG. Enhanced oral bioavailability of docetaxel in rats by four consecutive days of pre-treatment with curcumin. Int J Pharm. 2010;399:116-20.
7. Yin YM, Cui FD, Mu CF, Choi MK, Kim JS, Chung SJ, et al. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Rel. 2009;140:86-94.
8. Gao K, Sun J, Liu K, Liu X, He Z. Preparation and characterization of a submi-cron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm. 2008;34:1227-37.
9. McDonald SL, Stevenson DA, Moir SE, Hutcheon AW, Haites NE, et al. Genomic changes identified by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines. Eur J Cancer. 2005;41:1086-94. (Pubitemid 40602862)
10. Elsabahy M, Perron ME, Bertrand N, Yu GE, Leroux JC. Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles. Biomacromolecules. 2007;8:2250-7. (Pubitemid 47104311)
11. Du W, Hong L, Yao T, Yang X, He Q, Yang B, et al. Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid. Bioorg Med Chem. 2007;15:6323-30. (Pubitemid 47088946)
12. Esmaeili F, Dinarvand R, Ghahremani MH, Amini M, Rouhani H, Sepehri N, et al. Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies. J Pharm Sci. 2009;98:2718-30.
13. Straubinger RM, Balasubramanian SV. Preparation and characterization of taxane-containing liposomes. Methods Enzymol. 2005;391:97-117. (Pubitemid 40259698)
14. Chen J, Qiu L, Hu M, Jin Y, Han J. Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel. Drug Dev Ind Pharm. 2008;34:588-94. (Pubitemid 351878675)
15. Esmaeili F, Dinarvand R, Ghahremani MH, Ostad SN, Esmaily H, Atyabi F. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles. Anticancer Drugs. 2010;21:43-52.
16. Malingré MM, Richel DJ, Beijnen JH, Rosing H, Koopman FJ, Huinink WW, et al. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. J Clin Oncol. 2001;19:1160-6. (Pubitemid 32176294)
17. Engels FK, Mathot RA, Loos WJ, van Schaik RH, Verweij J. Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel. Cancer Biol Ther. 2006;5:833-9. (Pubitemid 44775143)
18. Ben Reguiga M, Bonhomme-Faivre L, Farinotti R. Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in rats. J Pharm Pharmacol. 2007;59:401-8. (Pubitemid 47050905)
19. Yuan Y, Ying C, Li Z, Ping ZH, Sha GY, Bo Z, et al. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int J Pharm. 2012;430:114-9.
20. Choi HG, Kim MH, Lee MK, Kim CK. Effect of additives on the physicochemical properties of liquid suppository. Int J Pharm. 1999;190:13-9. (Pubitemid 29467467)
21. Yong CS, Choi JS, Quan QZ, Rhee JD, Kim CK, Lim SJ, et al. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm. 2001;226:195-205. (Pubitemid 32800794)
22. Choi HG, Jung JH, Ryu JM, Yoon SJ, Sung Oh YK, et al. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm. 1998;165:33-44. (Pubitemid 28218342)
23. Xuan JJ, Balakrishnan P, Oh DH, Yeo WH, Park SM, Yong CS, et al. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. Int J Pharm. 2010;395:317-23.
24. Mu CF, Balakrishnan P, Cui FD, Yin YM, Lee YB, Choi HG, et al. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials. 2010;31:2371-9.
25. Yun MO, Choi HG, Jung JH, Kim CK. Development of thermoreversible insulin liquid suppository with sodium salicylate. Int J Pharm. 1999;189:137-45. (Pubitemid 29481749)
26. Yong CS, Yang CH, Rhee JD, Lee BJ, Kim DC, Kim DD, et al. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. Int J Pharm. 2004;269:169-76. (Pubitemid 38032832)
27. Ray A, Larson N, Pike DB, Greuner M, Naik A, Bauer H, et al. Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer RGDfK conjugates. Mol Pharm. 2011;8:1090-9.
28. Sakai M, Hobara N, Hokama N, Kameya H, Ohshiro S, Sakanashi M, et al. Increased bioavailability of tacrolimus after rectal administration in rats. Biol Pharm Bull. 2004;27:1480-2. (Pubitemid 41701701)
29. Chen MJ, Cheng YM, Lai PH, Wu JF, Hsu YC. In vitro biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemoprevention. Int J Colorectal Dis. 2012;27:869-78.
30. Barakat NS. In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac. APPS Pharm Sci Tech. 2009;10:724-31.
31. Mayol L, Biondi M, Quaglia F, Fusco S, Borzacchiello A, La AL, et al. Injectable thermally responsive mucoadhesive gel for sustained protein delivery. Biomacromolecules. 2011;12:28-33.
32. Yang Y, Wang J, Zhang X, Lu W, Zhang Q. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. J Control Rel. 2009;135:175-82.
33. Hu K, Cao S, Hu F, Feng J. Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation. Int J Nanomed. 2012;7:3537-45.
34. Kim JK, Kim MS, Park JS, Kim CK. Thermo-reversible flurbiprofen liquid suppository with HP-b-CD as a solubility enhancer: improvement of rectal bioavailability. J Incl Phenom Macrocycl Chem. 2009;64:265-72.
35. Wang L, Li M, Zhang N. Folate-targeted docetaxel-lipid-based- nanosuspensions for active-targeted cancer therapy. Int J Nanomed. 2012;7:3281-94.
36. Xu Z, Chen L, Gu W, Gao Y, Lin L, Zhang Z, et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials. 2009;30:226-32.
37. Koo AN, Min KH, Lee HJ, Lee SU, Kim K, Kwon IC, et al. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Biomaterials. 2012;33:1489-99.
38. Varma RK, Kaushal R, Junnarkar AY, Thomas GP, Naidu MU, Singh PP, et al. Polysorbate 80: a pharmacological study. Arzneimittelforschung. 1985;35:804-8. (Pubitemid 15056752)